Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 7036 to 7050 of 7679 results

  1. Bimekizumab for treating active non-radiographic axial spondyloarthritis [ID4010]

    Discontinued [GID-TA11151]

  2. Venous thromboembolism (VTE) - ximelagatran [ID396]

    Discontinued [GID-TAG378]

  3. Bimekizumab for treating ankylosing spondylitis ID4011

    Discontinued [GID-TA11171]

  4. Letermovir for preventing cytomegalovirus infection after a kidney transplant [ID6166]

    In development [GID-TA11107] Expected publication date: TBC

  5. Preterm labour and birth - predicting preterm birth

    Discontinued [GID-NG10384]

  6. Nivolumab for maintenance treatment of extensive stage small-cell lung cancer after chemotherapy [ID1264]

    Discontinued [GID-TA10365]

  7. Pembrolizumab with lenvatinib for previously treated metastatic colorectal cancer [ID5112]

    In development [GID-TA11020] Expected publication date: TBC

  8. Preterm labour and birth - timing of cord clamping

    Discontinued [GID-NG10396]

  9. Intrapartum care for healthy women and babies - angle of episiotomy

    Discontinued [GID-NG10394]

  10. Daratumumab with bortezomib, lenalidomide and dexamethasone for untreated multiple myeloma when high-dose chemotherapy with stem cell transplant is unsuitable [ID3843]

    In development [GID-TA10726] Expected publication date: TBC

  11. Intrathecal idursulfase for treating Mucopolysaccharidosis type II ID1223

    Discontinued [GID-HST10019]

  12. Nivolumab with ipilimumab for untreated PD-L1 positive unresectable or metastatic urothelial cancer [ID3829]

    Discontinued [GID-TA10707]

  13. Ticagrelor for preventing stroke after previous ischaemic stroke or high-risk transient ischaemic attack [ID2689]

    Discontinued [GID-TA10663]

  14. Terevalefim for treating delayed graft function after kidney transplant [ID1490]

    Discontinued [GID-TA11098]